Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$0.08 - $809.55 $8 - $80,955
-100 Reduced 0.09%
117,183 $10,000
Q3 2022

Nov 09, 2022

BUY
$0.17 - $765.0 $266 - $1.2 Million
1,566 Added 1.35%
117,283 $18,000
Q2 2022

Aug 11, 2022

BUY
$0.27 - $0.71 $5,213 - $13,709
19,309 Added 20.03%
115,717 $34,000
Q1 2022

May 12, 2022

BUY
$0.38 - $1.07 $12,868 - $36,234
33,864 Added 54.14%
96,408 $68,000
Q4 2021

Feb 11, 2022

BUY
$1.03 - $2.48 $15,906 - $38,298
15,443 Added 32.79%
62,544 $65,000
Q3 2021

Nov 12, 2021

BUY
$2.14 - $4.95 $100,796 - $233,149
47,101 New
47,101 $107,000

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $127M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.